Our findings thus unravel a novel LIN28/MSI2-YAP1 regulatory axis to induce the CSC properties, tumor growth and metastasis, which may serve as a potential therapeutic strategy for the treatment of a subset of TNBC with LIN28 overexpression. This evidence concerns the gene MSI2 and neoplasm.